Ligand completes $739M acquisition of XOMA Royalty Corporation

🌐 Investing.com (CY) —
Ligand completes $739M acquisition of XOMA Royalty Corporation

AI Summary

Ligand Pharmaceuticals completed its acquisition of XOMA Royalty Corporation for $739 million, expanding its portfolio and market presence. This strategic deal underscores Ligand's growth strategy through significant corporate acquisitions.

Markets Deals Ligand Pharmaceuticals XOMA Royalty Corporation acquisition corporate deal market expansion investment

Read original source →